| Primary |
| Completed Suicide |
25.0% |
| General Anaesthesia |
25.0% |
| Perioperative Analgesia |
25.0% |
| Prophylaxis Of Nausea And Vomiting |
25.0% |
|
| Anaphylactoid Shock |
16.7% |
| Intentional Overdose |
16.7% |
| Paralysis Flaccid |
16.7% |
| Tricuspid Valve Incompetence |
16.7% |
| Ventricular Fibrillation |
16.7% |
| Wrong Drug Administered |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
15.3% |
| Anaesthesia |
11.7% |
| Sedation |
8.8% |
| Premedication |
7.0% |
| General Anaesthesia |
6.1% |
| Induction Of Anaesthesia |
4.9% |
| Foetal Exposure During Pregnancy |
4.2% |
| Drug Exposure Via Mother |
2.9% |
| Preoperative Care |
2.8% |
| Prophylaxis |
2.7% |
| Postoperative Care |
1.8% |
| Anaesthesia Procedure |
1.0% |
| Epilepsy |
1.0% |
| Surgery |
1.0% |
| Aspergillosis |
0.9% |
| Back Pain |
0.8% |
| Endotracheal Intubation |
0.8% |
| Hysterectomy |
0.8% |
| Motor Dysfunction |
0.8% |
|
| Renal Failure Acute |
34.8% |
| Rhabdomyolysis |
11.4% |
| Anaphylactic Reaction |
6.8% |
| Thrombocytopenia |
6.1% |
| Cardiac Arrest |
4.5% |
| Premature Baby |
4.5% |
| Shock |
3.8% |
| Tachycardia |
3.8% |
| Anaphylactic Shock |
3.0% |
| Maternal Exposure Timing Unspecified |
3.0% |
| Foetal Growth Restriction |
2.3% |
| Injection Site Thrombosis |
2.3% |
| Renal Tubular Necrosis |
2.3% |
| Stress Cardiomyopathy |
2.3% |
| Conversion Disorder |
1.5% |
| Liver Function Test Abnormal |
1.5% |
| Penile Vascular Disorder |
1.5% |
| Rash |
1.5% |
| Respiratory Disorder |
1.5% |
| Stridor |
1.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.5% |
| Product Used For Unknown Indication |
22.1% |
| Anaesthesia |
11.8% |
| General Anaesthesia |
7.6% |
| Induction Of Anaesthesia |
7.0% |
| Intraoperative Care |
4.0% |
| Prophylaxis |
3.7% |
| Depression |
3.4% |
| Sedation |
2.2% |
| Maintenance Of Anaesthesia |
2.1% |
| Antiemetic Supportive Care |
1.8% |
| Hypertension |
1.8% |
| Analgesic Therapy |
1.5% |
| Local Anaesthesia |
1.2% |
| Nerve Block |
1.2% |
| Antibiotic Prophylaxis |
1.0% |
| Premedication |
1.0% |
| Supraventricular Tachycardia |
1.0% |
| Analgesia |
0.9% |
| Back Pain |
0.9% |
|
| Tremor |
21.7% |
| Muscle Spasms |
8.7% |
| Ventricular Tachycardia |
7.2% |
| Laryngospasm |
5.8% |
| Renal Failure Acute |
5.8% |
| Thrombocytopenia |
5.8% |
| Anaphylactic Reaction |
4.3% |
| Blister |
4.3% |
| Hypokalaemia |
4.3% |
| Liver Function Test Abnormal |
4.3% |
| Unresponsive To Stimuli |
4.3% |
| Hypertension |
2.9% |
| Hypoxia |
2.9% |
| Oxygen Saturation Decreased |
2.9% |
| Serotonin Syndrome |
2.9% |
| Upper Airway Obstruction |
2.9% |
| Upper Respiratory Tract Infection |
2.9% |
| Vomiting |
2.9% |
| Acute Myocardial Infarction |
1.4% |
| Agranulocytosis |
1.4% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Perioperative Analgesia |
32.1% |
| Induction Of Anaesthesia |
7.1% |
| Back Pain |
3.6% |
| Insomnia |
3.6% |
| Prophylaxis |
3.6% |
|
| Drug Interaction |
66.7% |
| Ventricular Fibrillation |
33.3% |
|
